Cellcolabs
Cellcolabs produces bone-marrow–derived mesenchymal stem cells (MSCs) at industrial scale using GMP-certified manufacturing processes. The company provides high-quality, cryopreserved cells to support clinical research and global medical collaborations. Its production facility operates under the oversight of the Swedish Medical Products Agency to ensure pharmaceutical-grade safety and consistency.
Visit websiteSolna, Sweden
Healthtech
Biotechnology
Life Sciences
Healthcare
Funding summary
- Total raised
- €24.5M
- Funding rounds
- 3
Investors in Cellcolabs
Investors on record for Cellcolabs. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Cellcolabs?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors